IP Library Assignment 067217/0739
Patent Assignment
Reel/Frame 067217/0739

Change of Name

Recorded: 2024-04-24 Pages: 3
Assignor
EXAGEN DIAGNOSTICS, INC.
Executed: 2019-01-02
Assignee
EXAGEN INC.
1261 LIBERTY WAY, SUITE C, VISTA, CALIFORNIA, 92081
Covered Properties (2)
Methods for Treating and Diagnosing Systemic Lupus Erythematosus
Application: 17/993,502 →
Publication: US 2023/0194553
Methods for Treating and Diagnosing Systemic Lupus Erythematosus by Measuring Levels of Biomarkers, Such as Erythrocyte-Bound C4D, B-Lymphocyte-Bound C4D, Anti-Sjogren's Syndrome Type B Antigen, Scl-70 Antibody, Jo-1 Antibody, and Anti-Centromere Protein B, in Subjects; Identifying Subjects as Having Systemic Lupus Erythematosus Based on Biomarker Levels; and Treating Subjects for Systemic Lupus Erythematosus
Application: 18/125,400 →
Publication: US 2023/0228768
Related Assignments (2)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 24, 2024
From: DERVIEUX, THIERRY; BARKEN, DERREN
To: EXAGEN DIAGNOSTICS, INC.
Reel/Frame 067214/0775 →
Security Interest Apr 25, 2025
From: EXAGEN INC.
To: PERCEPTIVE CREDIT HOLDINGS IV, LP
Reel/Frame 070952/0802 →